BR112012021624A2 - uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor. - Google Patents
uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor.Info
- Publication number
- BR112012021624A2 BR112012021624A2 BR112012021624A BR112012021624A BR112012021624A2 BR 112012021624 A2 BR112012021624 A2 BR 112012021624A2 BR 112012021624 A BR112012021624 A BR 112012021624A BR 112012021624 A BR112012021624 A BR 112012021624A BR 112012021624 A2 BR112012021624 A2 BR 112012021624A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- mammal
- preventing
- treating
- antitumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 8
- 201000011510 cancer Diseases 0.000 title abstract 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 241000124008 Mammalia Species 0.000 title abstract 4
- 230000000259 anti-tumor effect Effects 0.000 title abstract 3
- 235000014655 lactic acid Nutrition 0.000 title abstract 3
- 239000004310 lactic acid Substances 0.000 title abstract 3
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MY2010/000307 WO2012074351A1 (en) | 2010-11-29 | 2010-11-29 | Tumour cytotoxic agent and methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012021624A2 true BR112012021624A2 (pt) | 2017-02-07 |
Family
ID=46172112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012021624A BR112012021624A2 (pt) | 2010-11-29 | 2010-11-29 | uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor. |
Country Status (7)
Country | Link |
---|---|
US (2) | US9480721B2 (pt) |
EP (1) | EP2646042A4 (pt) |
JP (1) | JP5913353B2 (pt) |
KR (1) | KR101747815B1 (pt) |
BR (1) | BR112012021624A2 (pt) |
SG (1) | SG183544A1 (pt) |
WO (1) | WO2012074351A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10231941B2 (en) | 2015-01-23 | 2019-03-19 | Temple University—Of The Commonwealth System of Higher Educaton | Use of short chain fatty acids in cancer prevention |
US11065217B2 (en) | 2017-01-27 | 2021-07-20 | Temple University—Of the Commonwealth System of Higher Education | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
WO2022068924A1 (zh) * | 2020-09-30 | 2022-04-07 | 成都夸常奥普医疗科技有限公司 | 益生菌组分的应用以及包含益生菌组分的药物组合物 |
WO2022203303A1 (ko) * | 2021-03-22 | 2022-09-29 | 주식회사 지아이바이옴 | 락토바실러스 플란타럼 gb104 균주 및 이를 포함하는 암 예방 또는 치료용 조성물 |
TW202342077A (zh) * | 2022-02-10 | 2023-11-01 | 南韓商Gi生物群系公司 | 使用包括植物乳桿菌菌株和抗癌劑的組合施用療法的用於預防或治療癌症的組合物 |
CN116144530B (zh) * | 2022-11-17 | 2023-07-21 | 朗恒科技集团有限公司 | 一株植物乳杆菌ay01及其应用 |
KR20240123764A (ko) * | 2023-02-06 | 2024-08-14 | 주식회사 지아이바이옴 | 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009093447A1 (ja) * | 2008-01-22 | 2009-07-30 | National University Corporation Asahikawa Medical College | 消化器癌に対する抗腫瘍剤 |
WO2010064373A1 (ja) * | 2008-12-04 | 2010-06-10 | 国立大学法人広島大学 | Il-8阻害剤およびその製造方法 |
CN102292430B (zh) * | 2009-04-09 | 2014-11-19 | 马来西亚博特拉大学 | 单胃动物饲料 |
MY158907A (en) * | 2009-08-10 | 2016-11-30 | Univ Putra Malaysia Upm | Metabolites in animal feed |
-
2010
- 2010-11-29 WO PCT/MY2010/000307 patent/WO2012074351A1/en active Application Filing
- 2010-11-29 BR BR112012021624A patent/BR112012021624A2/pt not_active IP Right Cessation
- 2010-11-29 SG SG2012064184A patent/SG183544A1/en unknown
- 2010-11-29 EP EP10860122.0A patent/EP2646042A4/en not_active Withdrawn
- 2010-11-29 JP JP2013540910A patent/JP5913353B2/ja not_active Expired - Fee Related
- 2010-11-29 KR KR1020137004057A patent/KR101747815B1/ko active IP Right Grant
- 2010-11-29 US US13/579,936 patent/US9480721B2/en not_active Expired - Fee Related
-
2015
- 2015-10-19 US US14/886,782 patent/US20160030492A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2010365001A1 (en) | 2012-08-30 |
US20130323215A1 (en) | 2013-12-05 |
EP2646042A1 (en) | 2013-10-09 |
JP2014500263A (ja) | 2014-01-09 |
US20160030492A1 (en) | 2016-02-04 |
KR101747815B1 (ko) | 2017-06-15 |
US9480721B2 (en) | 2016-11-01 |
KR20130132398A (ko) | 2013-12-04 |
EP2646042A4 (en) | 2014-07-23 |
JP5913353B2 (ja) | 2016-04-27 |
WO2012074351A1 (en) | 2012-06-07 |
SG183544A1 (en) | 2012-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012021624A2 (pt) | uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor. | |
PH12019500521A1 (en) | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer | |
EP4140487A8 (en) | Combination therapy for treating cancer | |
MX2016007351A (es) | Terapia de combinacion para tratar cancer. | |
MX2021013830A (es) | Inhibidores de ezh2 para tratar linfomas. | |
NZ706296A (en) | Glucosylceramide synthase inhibitors | |
MX2019008428A (es) | Inhibidores de glucosilceramida sintasa. | |
BR112018007447A2 (pt) | terapia de combinação para tratamento de malignidades | |
MX2013008212A (es) | Derivados de 7-azaindol. | |
PH12014501639A1 (en) | Pharmaceutical compositions and methods | |
SG178873A1 (en) | Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors | |
BR112015002706A8 (pt) | Niclosamida e seus derivados para uso no tratamento de tumores sólidos | |
IL207310A (en) | Vaccines | |
BR112018007671A2 (pt) | terapia de combinação para tratamento de malignidades | |
PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
BR112012022243A2 (pt) | terapias inibidoras de autografia baseadas em tioxantona para tratar câncer | |
MX2013006319A (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k y un inhibidor de mek. | |
MX2014010749A (es) | Composicion ginecologica para tratar la vestibulitis vulvar. | |
TN2014000418A1 (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
TN2013000368A1 (en) | Glucosylceramide synthase inhibitors | |
IN2015DN01223A (pt) | ||
TN2013000247A1 (en) | Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2449 DE 12/12/2017 POR TER SIDO INDEVIDA. |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018. |